$100K - $150K*
Agios is a biopharmaceutical company committed to applying our scientific leadership in cellular metabolism to transform the lives of patients with cancer and rare genetic diseases. We are growing rapidly with an active research and discovery pipeline across both therapeutic areas. Agios has two approved oncology precision medicines and multiple first-in-class investigational therapies in clinical and/or preclinical development.
We are currently seeking an innovative Clinical Development leader to help drive our rare disease development program. Reporting into our Vice President for Rare Genetic Diseases (RGD), this person will advance Agios' research activities and pipeline targeting Inborn Errors of Metabolism (IEMs).
The Medical Director/Senior Medical Director will be responsible for the development and execution of clinical research and development programs for Agios Pharmaceuticals including the leadership of the pivotal trials, NDA and filing activities.
Valid through: 2020-3-5